Authored By: Sarah
15 Jul 2024

 Amniotic Membrane Market to grow by USD 2724.8 million between 2024-2028

According to a research report “ Amniotic Membrane Market” by End-user (Hospitals, Ambulatory surgical centers, Specialty clinics, Research and academic institutes) Type (Cryopreserved amniotic membrane, Dehydrated amniotic membrane) Geography (North America, Europe, Asia, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 2724.8 million at a CAGR of about 15.19% during the forecast period. The amniotic membrane market is experiencing robust growth due to the transformative impact of amniotic membrane transplantations on ophthalmic treatments. These membranes facilitate epithelial cell migration, reinforce adhesion, and encourage diffusion, making them invaluable in ocular surface reconstruction for conditions like bullous keratopathy, glaucoma, cataract, partial limbal stem cell deficiency, persistent epithelial defects, and corneoscleral ulcers. Moreover, their anti-inflammatory properties and ability to modulate stromal scarring expand their application in acute burn cases as alternatives for conjunctival and corneal reconstruction..

Browse market data tables, figures, and in-depth TOC on “Amniotic Membrane Market” by End-user (Hospitals, Ambulatory surgical centers, Specialty clinics, Research and academic institutes) Type (Cryopreserved amniotic membrane, Dehydrated amniotic membrane) Geography (North America, Europe, Asia, Rest of World (ROW)) Global Forecast to 2028.

 View detailed Table of Content- Click here

By End-user, the Hospitals segment is projected to dominate the market size in 2024.

The amniotic membrane market is experiencing significant growth due to the advancements in cryopreservation technology. By slow-freezing membranes at -112 degrees Fahrenheit using Dulbecco's modified eagle medium (DMEM) and glycerol, the integrity of the amniotic membrane and the native architecture of the extracellular matrix (ECM) are preserved during long-term storage. This process maintains the activity and quantity of essential biological signaling proteins, including pentraxin 3 complex, fibronectin, collagen, and heavy-chain hyaluronic acid. The resulting cryopreserved membranes offer valuable applications in anti-inflammatory therapies, ocular surface repair, wound healing, protective coverings, and regenerative procedures.

By Type, Cryopreserved amniotic membrane  segment is expected to hold the largest market size for the year 2024.

The amniotic membrane market witnesses significant growth due to its utilization in various medical sectors. In ophthalmology, it serves as an essential graft for promoting wound healing, reducing scarring, and treating ocular surface disorders in procedures like corneal and conjunctival reconstruction. Additionally, its application in chronic non-healing wounds, such as diabetic foot ulcers, venous leg ulcers, and burns, bolsters its demand as a biological dressing. The amniotic membrane's unique properties, including anti-inflammatory and anti-microbial capabilities, further expand its market potential.

North America is forecasted to hold the largest market size by region in 2024.

The Amniotic Membrane Market represents a significant business opportunity, driven by the increasing demand for advanced wound healing solutions. This market is characterized by the production and distribution of amniotic membrane-derived products, which offer numerous benefits, including rapid healing, reduced scarring, and minimal risk of infection. Companies in this sector are focused on research and development to expand their product portfolios and meet the evolving needs of healthcare providers and patients.

The Amniotic Membrane Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:

  • Amnio Technology LLC
  • Applied Biologics LLC
  • Celularity Inc.
  • Flower Orthopedics Corp.
  • Human Regenerative Technologies LLC
  • Integra Lifesciences Corp.
  • Katena Products Inc.
  • Merakris Therapeutics Inc.
  • MiMedx Group Inc.
  • Next Biosciences Pty Ltd.
  • NuVision Biotherapies Ltd
  • Organogenesis Holdings Inc.
  • Orthofix Medical Inc.
  • Reea carewell products
  • Skye Biologics Holdings LLC
  • Stryker Corp.
  • Surgenex LLC
  • TissueTech Inc.

For insights on company offerings- Request a sample report!

Research Analysis Overview

The Amniotic Membrane Market encompasses the production, distribution, and sale of Amniotic Allografts, a type of Wound Care Biologic derived from human Amniotic Membranes. These membranes offer numerous benefits for various medical treatments, including Ophthalmology and surgical wound care. Amniotic Allografts are available in various forms, such as lyophilized amniotic tissue, cryopreserved amniotic tissue, and frozen amniotic tissue. Amniotic Membranes possess unique properties, including Anti-inflammatory, Antibacterial, and Anti-scarring properties, making them an ideal solution for non-healing chronic wounds and Ocular diseases like Dry Eye Disease. In the field of Eye care, Amniotic Transplants have proven effective in treating corneal epithelia defects and improving vision. The advancement of Drug Development Technology has led to the exploration of Amniotic Membranes' potential in treating Chronic Diseases and Blood vessel injuries. Amniotic providers offer these medical treatments to patients, ensuring the highest quality and safety standards. The market for Amniotic Membranes continues to grow as more surgeries and medical treatments adopt this innovative biologic for Wound care and Ophthalmology applications.

Market Research Overview

The Amniotic Membrane Market encompasses the production, sale, and application of amniotic membrane-derived products in various healthcare segments. These advanced and alternative solutions cater to unmet healthcare needs, particularly in surgical subspecialties such as the Hospital segment and the ASCs segment. The Ophthalmology segment holds significant market share due to the use of amniotic membranes in eye care, including corneal ulcers, pterygium excisions, and ocular diseases. Amniotic membranes offer numerous benefits, including the availability of stem cells, dehydrated amniotic tissue, and cryopreserved amniotic tissue. These tissue-based products exhibit antibacterial, anti-inflammatory, and anti-scarring properties, making them ideal for wound healing and pain management in various surgical wounds segments, such as pressure ulcers and avascular stromal wounds. Moreover, the market for amniotic membranes is driven by medical advancements in regenerative medicine, including the use of amniotic membranes in limbic stem cell therapy, drug development technology, and transplant procedures. Amniotic membranes are also used in burn treatment, cosmetic surgeries, and orthopedics surgeries. In summary, the Amniotic Membrane Market represents a growing and diverse industry, providing innovative solutions for a wide range of healthcare needs and surgical applications.


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200

Read News Read Less
Interested in this report?
Get your sample now!